It is not known whether exposure to cannabis or cannabis-derived compounds restores the DNAm and expression levels of CACNA1C to those of non-carriers or whether the restoration is associated with an improvement in depression symptoms; these questions need further investigation. This evidence concerns the gene CACNA1C and depressive symptom measurement.